دورية أكاديمية

Unexplained Vision Loss Associated With Intraocular Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment Repair.

التفاصيل البيبلوغرافية
العنوان: Unexplained Vision Loss Associated With Intraocular Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment Repair.
المؤلفون: Pakravan P; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Shaheen A; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Patel V; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Villalba MF; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Dib B; Department of Ophthalmology, University of Alabama, Birmingham, AL, USA., Lai J; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Rohowetz L; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Chau V; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Patel NA; Department of Ophthalmology, Massachusetts Eye and Ear infirmary, Harvard University, Boston, MA, USA., Tzu JH; Retina and Vitreous of Texas, Houston, TX, USA., Wang AL; Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Alhoyek S; Department of Ophthalmology, Massachusetts Eye and Ear infirmary, Harvard University, Boston, MA, USA., Scott N; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Samara WA; Department of Ophthalmology, University of Alabama, Birmingham, AL, USA., Goduni L; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Jung JJ; Department of Ophthalmology, University of California, San Francisco, CA, USA., Russell JF; Institute for Vision Research and Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA., Mantopoulos D; Diseases of the Retina and Vitreous, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA., Hajrasouliha AR; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA., Savoie BT; Department of Ophthalmology at Brown University, Providence, RI, USA., Haddock LJ; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Berrocal AM; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Sridhar J; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., West MR; Department of Ophthalmology, University of Alabama, Birmingham, AL, USA., Yannuzzi NA; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
المصدر: Journal of vitreoretinal diseases [J Vitreoretin Dis] 2023 Jun 10; Vol. 7 (4), pp. 299-304. Date of Electronic Publication: 2023 Jun 10 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101700301 Publication Model: eCollection Cited Medium: Internet ISSN: 2474-1272 (Electronic) Linking ISSN: 24741264 NLM ISO Abbreviation: J Vitreoretin Dis Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Thousand Oaks, CA : Sage Publications, [2017]-
مستخلص: Purpose: To evaluate the visual outcomes with unexplained vision loss during or after silicone oil (SO) tamponade. Methods: This multicenter retrospective case series comprised patients with unexplained vision loss associated with SO tamponade or its removal. Eyes with other clear secondary identifiable causes of vision loss were excluded. Results: Twenty-nine eyes of 28 patients (64% male) were identified. The mean age was 50 ± 13 years (range, 13-78 years). The mean duration of SO tamponade was 148 ± 38 days. Eighteen eyes (62%) developed unexplained vision loss while under SO; 11 (38%) had vision loss after SO removal. The most common optical coherence tomography (OCT) finding was ganglion cell layer (GCL) thinning (55%). Eyes with vision loss after SO removal had a mean logMAR best-corrected visual acuity (BCVA) of 0.6 ± 0.7 (Snellen 20/85) before SO tamponade and 1.2 ± 0.4 (20/340) before SO removal. By the last follow-up after SO removal, the BCVA had improved to 1.1 ± 0.4 (20/235). In eyes with vision loss after SO removal, the BCVA before SO removal was 0.7 ± 0.7 (20/104), which deteriorated to 1.4 ± 0.4 (20/458) 1 month after SO removal. By the last follow-up, the BCVA had improved to 1.0 ± 0.5 (20/219). Conclusions: Unexplained vision loss can occur during SO tamponade or after SO removal. Vision loss was associated with 1000-centistoke and 5000-centistoke oil and occurred in macula-off and macula-on retinal detachments. The duration of tamponade was 3 months or longer in the majority of eyes. Most eyes had GCL thinning on OCT. Gradual visual recovery can occur yet is often incomplete.
Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Yannuzzi is on Advisory Board of Genentech and RegenXbio. Dr. Mantopoulos is a consultant to Alimera Sciences. Dr. Goduni has served on the Alimera Fellows Advisory Board and is an independent contractor for Clover Therapeutics. Dr. Jung is a consultant to Carl Zeiss Meditec, Inc.
(© The Author(s) 2023.)
References: Retina. 2016 Feb;36(2):342-50. (PMID: 26308530)
Retina. 2010 Feb;30(2):300-4. (PMID: 19920769)
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):35-9. (PMID: 22562478)
Int J Retina Vitreous. 2017 Jul 24;3:26. (PMID: 28748109)
Br J Ophthalmol. 2005 Jul;89(7):799-802. (PMID: 15965152)
Retina. 2004 Dec;24(6):871-7. (PMID: 15579983)
Acta Ophthalmol. 2012 Dec;90(8):733-7. (PMID: 21914150)
Eye (Lond). 2015 Nov;29(11):1477-82. (PMID: 26248526)
Clin Ophthalmol. 2008 Dec;2(4):955-9. (PMID: 19668452)
Invest Ophthalmol Vis Sci. 2000 Jan;41(1):256-61. (PMID: 10634628)
J Neuroophthalmol. 2016 Dec;36(4):417-438. (PMID: 27636747)
Acta Ophthalmol. 2016 Aug;94(5):449-53. (PMID: 26806559)
Br J Ophthalmol. 2005 Dec;89(12):1668. (PMID: 16299160)
Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):248-52. (PMID: 16047183)
Ophthalmol Ther. 2020 Sep;9(3):1-13. (PMID: 32399859)
Am J Ophthalmol. 1971 May;71(5):1044-51. (PMID: 5562510)
معلومات مُعتمدة: P30 EY014801 United States EY NEI NIH HHS
فهرسة مساهمة: Keywords: intraocular silicone oil tamponade; rhegmatogenous retinal detachment repair; unexplained vision loss
تواريخ الأحداث: Date Created: 20231106 Latest Revision: 20240611
رمز التحديث: 20240611
مُعرف محوري في PubMed: PMC10621697
DOI: 10.1177/24741264231161121
PMID: 37927311
قاعدة البيانات: MEDLINE
الوصف
تدمد:2474-1272
DOI:10.1177/24741264231161121